545 results on '"Kwekkeboom, Jaap"'
Search Results
102. Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer
103. Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation
104. Donor-specific anti-HLA antibodies are not associated with nonanastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation
105. Addendum to “MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantation” [J Hepatol 2013;59:1231–1238]
106. Dynamics of Proliferative and Quiescent Stem Cells in Liver Homeostasis and Injury
107. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas
108. Cross-Tissue Transcriptomic Analysis of Human Secondary Lymphoid Organ-Residing ILC3s Reveals a Quiescent State in the Absence of Inflammation
109. Protective Cytomegalovirus (CMV)-Specific T-Cell Immunity Is Frequent in Kidney Transplant Patients without Serum Anti-CMV Antibodies
110. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections
111. Immunomodulation by hyperimmunoglobulins after solid organ transplantation: Beyond prevention of viral infection
112. PD-L1, Galectin-9 and CD8+ tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma
113. MOESM1 of Differential Sensitivities of Fast- and Slow-Cycling Cancer Cells to Inosine Monophosphate Dehydrogenase 2 Inhibition by Mycophenolic Acid
114. Modeling liver cancer and therapy responsiveness using organoids derived from primary mouse liver tumors.
115. Action and clinical significance of CCAAT/enhancer-binding protein delta in hepatocellular carcinoma.
116. Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies (vol 40, pg 513, 2014)
117. Counter-regulation of rejection activity against human liver grafts by donor PD-L1 and recipient PD-1 interaction
118. Reply to: Comment on ‘Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area’
119. Prominent HLA-G Expression in Liver Disease But Not After Liver Transplantation
120. High-dose intravenous immunoglobulin does not reduce the numbers of circulating CD14(+)CD16(++) monocytes in patients with inflammatory disorders (vol 145, pg 11, 2012)
121. Prognostic value of intra‐tumoral CD8+/FoxP3+ lymphocyte ratio in patients with resected colorectal cancer liver metastasis.
122. Polarized release of hepatic microRNAs into bile and serum in response to cellular injury and impaired liver function
123. Cytomegalovirus-Induced Expression of CD244 after Liver Transplantation Is Associated with CD8+ T Cell Hyporesponsiveness to Alloantigen
124. Human Graft-Derived Mesenchymal Stromal Cells Potently Suppress Alloreactive T-Cell Responses
125. GITR engagement in combination with CTLA-4 blockade completely abrogates immunosuppression mediated by human liver tumor-derived regulatory T cellsex vivo
126. Differences in Anti-Inflammatory Actions of Intravenous Immunoglobulin between Mice and Men: More than Meets the Eye
127. Tumor-infiltrating plasmacytoid dendritic cells promote immunosuppression by Tr1 cells in human liver tumors
128. Increased Incidence of Early De Novo Cancer in Liver Graft Recipients Treated with Cyclosporine: An Association with C-2 Monitoring and Recipient Age
129. Calcineurin Inhibitor Tacrolimus Does Not Interfere with the Suppression of Hepatitis C Virus Infection by Interferon-alpha
130. Kupffer Cells Interact With Hepatitis B Surface Antigen In Vivo and In Vitro, Leading to Proinflammatory Cytokine Production and Natural Killer Cell Function
131. Rotterdam: Main port for organ transplantation research in the Netherlands
132. Disturbance of the microRNA pathway by commonly used lentiviral shRNA libraries limits the application for screening host factors involved in hepatitis C virus infection
133. Allosuppressive donor CD4(+)CD25(+) regulatory T cells detach from the graft and circulate in recipients after liver transplantation
134. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections.
135. Functional impairment of myeloid and plasmacytoid dendritic cells of chronic hepatitis B patients
136. Genetic variance in ABCB1 and CYP3A5 does not contribute toward the development of chronic kidney disease after liver transplantation
137. Intravenous Immunoglobulin Treatment in Humans Suppresses Dendritic Cell Function via Stimulation of IL-4 and IL-13 Production
138. Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach
139. Mo1033 Tumor Antigen Expression Differs in Hepatocellular Carcinoma (HCC) Between Viral Hepatitis and Non-Viral Hepatitis Patients
140. Genetic variation in TNFA predicts protection from severe bacterial infections in patients with end-stage liver disease awaiting liver transplantation
141. Erratum: Granzyme expression in fine-needle aspirates from liver allografts is increased during acute rejection
142. Cancer inflammation and inflammatory biomarkers: can neutrophil, lymphocyte, and platelet counts represent the complexity of the immune system?
143. MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantation
144. Detection of spontaneous tumorigenic transformation during culture expansion of human mesenchymal stromal cells
145. CD154 is expressed during treatment with calcineurin inhibitors after organ transplantation
146. Erratum to “High-dose intravenous immunoglobulin does not reduce the numbers of circulating CD14+CD16++ monocytes in patients with inflammatory disorders” [Clin. Immunol. 145 (2012) 11–12]
147. T-cell suppression mediated by regulatory T cells infiltrating hepatic tumors can be overcome by GITRL treatment
148. Polarized release of hepatic micro RNAs into bile and serum in response to cellular injury and impaired liver function.
149. Separation of G-CSF-mobilized PBSC transplants by counterflow centrifugal elutriation: modest enrichment of CD34+ cells but no loss of primitive haemopoietic progenitors
150. Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.